Menu
Specialties
Urology
Gastroenterology
Rheumatology
Solutions
Provider Solutions
Group Purchasing (GPO)
Physician Dispensing, Infusions & Practice Operations
Population Health Management
Clinical & Business Intelligence
Research & Registries
Clinical Education & Training
Pharma Services
Real-World Data
Clinical Research & Patient Registries
Conference & Customer Engagement
Events
National Events
Practice-Specific
Role-Specific
Webinars
Company
About Us
Blog
Strategic Partners
Careers
Contact Us
Search
Search
Member Login
Specialties
Urology
Gastroenterology
Rheumatology
Solutions
Provider Solutions
Group Purchasing (GPO)
Physician Dispensing, Infusions & Practice Operations
Population Health Management
Clinical & Business Intelligence
Research & Registries
Clinical Education & Training
Pharma Services
Real-World Data
Clinical Research & Patient Registries
Conference & Customer Engagement
Events
National Events
Practice-Specific
Role-Specific
Webinars
Company
About Us
Blog
Strategic Partners
Careers
Contact Us
Search
Search
Member Login
Clinical Guidelines & Medical Policies
Table of Contents:
Urology
Gastroenterology
Rheumatology
UROLOGY
APC Clinical Guideline
BPH Clinical Guideline
Gonadotropin-Releasing Hormone Agonists – Injectable Long-Acting Products UM Medical De-Identified
Gonadotropin-Releasing Hormone Agonists – Injectable Long-Acting Products Utilization Management Medical Policy
GnRH Agonists – Lupron Depot and Lupaneta MA Policy
GnRH Agonists – Injectable Long-Acting Products MA Policy
OAB Clinical Guideline
Peyronie’s Disease Clinical Guideline
GASTROENTEROLOGY
IBD Pathway
Adult Practical Approach to IBD (Advanced Therapies)
Adult Practical Approach to IBD (5ASAs)
Basics of Advanced Therapy for IBD
Inflammatory Conditions
–
Cimzia UM Medical De-Identified
Inflammatory Conditions
–
Entyvio Intravenous UM Medical De-Identified
Inflammatory Conditions
–
Infliximab Products UM Medical De-Identified
Inflammatory Conditions – Infliximab Products Utilization Management Medical Policy
Inflammatory Conditions – Infliximab Products Utilization Management Medical Policy
Inflammatory Conditions
–
Simponi Aria UM Medical De-Identified
Inflammatory Conditions
–
Skyrizi Intravenous UM Medical De-Identified
Inflammatory Conditions
–
Stelara Intravenous UM Medical De-Identified
RHEUMATOLOGY
Axial Spondyloarthritis (axSpA) Clinical Guideline
Biosimilars in Rheumatology Clinical Guideline
GOUT Clinical Guideline
Hyaluronic Acid Derivatives (Intraarticular) Utilization Management Medical Policy
Hyaluronic Acid Derivatives (Intraarticular) Medicare Advantage Medical Utilization Review Policy
Hyaluronic Acid Derivatives (Intraarticular) Medicare Advantage Medical Utilization Review Policy
Hyaluronic Acid Derivatives (Intraarticular) Medicare Advantage Medical Utilization Review Policy
Inflammatory Conditions – Cimzia Utilization Management Medical Policy
Inflammatory Conditions – Infliximab Products Utilization Management Medical Policy
Inflammatory Conditions – Infliximab Products Medicare Advantage Medical Utilization Review Policy
Inflammatory Conditions – Infliximab Products Medicare Advantage (MA) Medical Utilization Review Policy
Inflammatory Conditions – Simponi Aria Utilization Management Medical Policy
Osteoarthritis of the Knee Clinical Guideline
Osteoporosis Clinical Guideline
Psoriatic Arthritis (PsA) Clinical Guideline
Rheumatoid Arthritis Clinical Guideline
Systemic Lupus Erythematosus Clinical Guideline
Ultrasound in Rheumatological Settings Clinical Guideline
Women’s Reproductive Health & Rheumatic Diseases Clinical Guideline